Research improves services and treatments not just for you but also for future generations. It helps develop new tests for diagnosis, treatments and processes that could eventually help your children, or even your grandchildren. By participating in research, you may gain access to treatments that are not yet readily available to the public.
Investigators Dr. Donald Cockcroft and Dr. Beth Davis from the Department of Medicine - Division of Respirology, Critical Care and Sleep Medicine at the University of Saskatchewan are inviting those between the ages of 18 and 65 who have been diagnosed with allergic asthma to participate in this clinical research study.
Tiotropium (Spiriva Respimat®) is a medication used to treat respiratory conditions. The purpose of this study is to investigate the protective effects of tiotropium on the response to allergen exposure in individuals with mild allergic asthma.
For more information about this study, including study design, eligibility criteria, procedures, and time commitment, please review the participant information and consent form link below.
To participate in this study, email investigator Dr. Beth Davis with your interest at email@example.com or call 306 844 1444.
This research study consists of a survey that includes questions on background health, health-related quality of life, respiratory symptoms, physical activity level, frequency of exacerbations, rescue inhaler use, and healthcare use during three different weather conditions:
- hot and humid
- cold and dry
- moderate or "ideal" temperature and humidity
The survey will take around 20-30 minutes to complete. We will provide a $20 Tim Horton's gift card as compensation for time and effort.
Researchers at the University of Saskatchewan (Rehabilitation Science and Kinesiology) are looking for survivors of COVID-19 aged 30-70 who were hospitalized or have/had symptoms that limit their physical activities, to complete a survey designed to document their symptoms and rehabilitation needs.
The survey is fairly short and should take less than 30 minutes to complete. If you are interested, please go to: https://www.surveymonkey.ca/r/COVID-REHAB.
For more information, please contact Dr. Scotty Butcher at firstname.lastname@example.org or 306-966-1711.
If you are a family with a child under 18 who is IC, we want to understand and document your experiences throughout COVID-19 in an interview and arts-based activity. Families from across Canada are invited to participate. Participants will receive an honorarium in appreciation of their participation.
Contact: email@example.com or call 204.474.8338
Researchers Dr. Kerri Johannson and Dr. Amanda Grant-Orser from the University of Calgary are conducting a survey to better understand the perspectives of Canadian Pulmonary Fibrosis patients, and their first degree relatives, on having access to genetic counseling and testing for mutations associated with Pulmonary Fibrosis.
The survey is anonymous and all data will be confidential. This study was approved by the University of Calgary's research ethics board (REB20-1553).
Canadian patients with Pulmonary Fibrosis and their first degree relatives e.g., parent, sibling, child, are invited to complete the survey at the link below.